Juhua Xiao1,2, Ting Sun3, Shouhua Zhang4, Ming Ma3, Xiaorong Yang3, Jinshui Zhou1, Jianfang Zhu1, Fang Wang5. 1. Department of HIFU Treatment Room, The First Affiliated Hospital of Nanchang University, No. 17, Yongwai Road, Nanchang, 330006, China. 2. Department of Ultrasound, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang, 330006, China. 3. Department of Urology Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, China. 4. Department of General Surgery, Jiangxi Children's Hospital, Nanchang, 330006, China. 5. Department of HIFU Treatment Room, The First Affiliated Hospital of Nanchang University, No. 17, Yongwai Road, Nanchang, 330006, China. wfwajwu@126.com.
Abstract
BACKGROUND: The current treatment therapies for chyluria are often invasive and recurrent. Here, we investigated a novel noninvasive treatment of chyluria with high-intensity focused ultrasound (HIFU) and evaluated its clinical efficacy. METHODS: 155 patients with chyluria were treated with HIFU ablation and followed up over a period of 15 years from May 2000 to December 2015. Routine examinations including urine color observation, color Doppler ultrasound examination, blood serum test of Cr, BUN, and albumin, and detection of urinary chyle were performed before and after the treatment, 1 week, 1 and 6 months post-treatment, and followed up via telephone and other forms. We lost contact with 54 patients during the course of the study. RESULTS: In the 101 complete cases, the serum levels of Cr and BUN and the color Doppler ultrasound examination did not reveal significant differences before and after the treatment. However, there was a significant increase in the hemoglobin and albumin levels, as well as the body weight after the HIFU treatment. The other 54 patients also showed an improvement of the symptoms after the HIFU treatment before losing contact. CONCLUSIONS: Our results suggest that the HIFU ablation therapy is a feasible, effective, and noninvasive method for the treatment of chyluria.
BACKGROUND: The current treatment therapies for chyluria are often invasive and recurrent. Here, we investigated a novel noninvasive treatment of chyluria with high-intensity focused ultrasound (HIFU) and evaluated its clinical efficacy. METHODS: 155 patients with chyluria were treated with HIFU ablation and followed up over a period of 15 years from May 2000 to December 2015. Routine examinations including urine color observation, color Doppler ultrasound examination, blood serum test of Cr, BUN, and albumin, and detection of urinary chyle were performed before and after the treatment, 1 week, 1 and 6 months post-treatment, and followed up via telephone and other forms. We lost contact with 54 patients during the course of the study. RESULTS: In the 101 complete cases, the serum levels of Cr and BUN and the color Doppler ultrasound examination did not reveal significant differences before and after the treatment. However, there was a significant increase in the hemoglobin and albumin levels, as well as the body weight after the HIFU treatment. The other 54 patients also showed an improvement of the symptoms after the HIFU treatment before losing contact. CONCLUSIONS: Our results suggest that the HIFU ablation therapy is a feasible, effective, and noninvasive method for the treatment of chyluria.
Authors: Johannes H Fruehauf; Walter Back; Alexa Eiermann; Michael-Christian Lang; Martin Pessel; Ernst Marlinghaus; Frank Melchert; Stefanie Volz-Köster; Joachim Volz Journal: Arch Gynecol Obstet Date: 2007-09-07 Impact factor: 2.344